Connect with us

CANNABIS SECTOR NEWS

Phoenix Life Signs Exclusive Agreement with Vanuatu Government for 25-Year Diabetes Management Program and Global Medical Cannabis Export License

Published

on

Phoenix Life Sciences International Limited (PLSI) (“Phoenix Life”, the “Company”), an adaptive healthcare solutions company, today announced that it has signed a binding Memorandum of Understanding (MOU) between the Company and the Ministry of Health on behalf of the Government of Vanuatu, located in the South Pacific. The MOU includes an exclusive 25-year diabetes management program, the creation of a national healthcare network, medical cannabis licensing and approval for Phoenix Life to export globally, both medical products for the targeted treatment of diabetes and generic medical cannabis products from the Republic of Vanuatu.

With this agreement, Phoenix Life will work with the Ministry of Health to establish a National Network of Community Healthcare Clinics and Dispensing Pharmacies throughout the country to manage the national Type 2 diabetes epidemic for a minimum of the next 25 years. These clinics will also provide dispensing of Phoenix Life’s diabetes management product, Phoenix Metabolic, as an alternative to insulin for the nation’s forecast more than 50,000 type 2 diabetics and an expected 50,000 high risk pre-diabetics.

Phoenix Metabolic uses active ingredients from extracts from the cannabis sativa plant, combined with bioavailability enhancement ensuring high levels of efficacy and safety in its use in managing type 2 diabetes and its complications. It is accurately dosed, doctor prescribed, pharmacy dispensed. By being non-psychoactive, is also ensures no impairment to the patient.

Phoenix Life is authorized to conduct screenings throughout the Republic of Vanuatu, including at Vila Central Hospital, to assess health conditions such as blood sugar levels, hypertension and overall wellness, among Ni-Vanuatu citizens. The work done at these Community Healthcare Clinics and Dispensing Pharmacies and the Company’s screening locations will provide a platform for patient access.

“This agreement is one of the core building blocks for our licensing, medical trials and the deployment of our strategy for launching programs to improve the treatment of type 2 diabetes and its complications on a global basis,” said Phoenix Life CEO and Founder, Martin Tindall. “We are thankful for this partnership with the Republic of Vanuatu and we look forward to creating a long and fruitful working relationship.”

Phoenix Life has already received an exemption from the Ministry of Health for the importation of products derived from medical cannabis to treat diabetes in compliance with the Dangerous Drugs Act for initial trials. The Company has also been approved to globally export medical products from Vanuatu for both the targeted diabetes products and generic medical cannabis products.

Additionally, as part of the agreement, Phoenix Life plans to develop training programs to educate medical professionals and support personnel on the best practices, uses of medical cannabis and improved management of type 2 diabetes and its complications. These programs will be created in conjunction with leading universities and colleges from the United States, Australia, New Zealand and The Republic of Vanuatu.

Phoenix Life intends to make this same program available to Governments and their health agencies throughout the world, and more specifically to the least developed countries and developing countries that cannot afford insulin programs. By creating this affordable program to bring solutions to those suffering from type 2 diabetes and its complications to these countries and their people, Phoenix Life is positioning itself to address the health and wellness of millions of diabetics worldwide.

To learn more about Phoenix Life Sciences International, please visit https://phoenixlife.co/. To learn more about Phoenix Life’s work in Vanuatu and how to register for blood sugar screenings, please visit https://phoenixlife.vu.

About Phoenix Life Sciences International Limited

Phoenix Life Sciences International Limited is an adaptive healthcare solutions company. Our business is to advance research and integrate programs and manufacturing of products that target and treat diabetes, pain, cancer, and address psychological, neurological, autoimmune and sleep disorders. We strive to create partnerships and integrate these programs for human health into communities worldwide as part of our Global Health Initiative.

Advertisement
Advertisement

TRENDING STORIES

INDUSTRIAL HEMP2 weeks ago

Digipath Inc. (OTCMKTS: DIGP) Announce Significant Milestones On Development Of GroSciences Hemp-Test Kit

Post Views: 236 Digipath Inc. (OTCMKTS:DIGP) has announced that its GroSciences subsidiary has made substantial progress in the development of...

INDUSTRIAL HEMP2 weeks ago

Harvest Health & Recreation Inc (OTCMKTS:HRVSF) Launches Expands Its Footprint In Florida With New Medical Marijuana dispensary in Gainesville

Post Views: 258 Harvest Health & Recreation Inc (OTCMKTS:HRVSF) recently announced that it launched a new outlet in Gainesville, making...

INDUSTRIAL HEMP2 weeks ago

Harvest Health & Recreation Inc (OTCMKTS:HRVSF) Gets Greenlight To Expand Its Foreign Private ISSUER Threshold

Post Views: 232 Harvest Health & Recreation Inc (OTCMKTS:HRVSF) revealed earlier this month that its Board of Directors has approved...

INDUSTRIAL HEMP2 weeks ago

Generex Biotechnology Corporation (OTCMKTS:GNBT) Adds MediSource Partners And Pantheon Medical To Its NuGenerex Family Of Subsidiaries

Post Views: 168 Generex biotechnology Corporation (OTCMKTS:GNBT) has welcomed MediSource Partners to its family of subsidiaries and introduced Pantheon Medical...

INDUSTRIAL HEMP2 weeks ago

CBD Unlimited Inc. (OTCMKTS:EDXC) Enhances Its Convenience Store Program Targeting 300 Stores

Post Views: 174 CBD Unlimited Inc. (OTCMKTS:EDXC), formerly Endexx Corporation, has announced an enhanced convenient store launch program. The provider...

INDUSTRIAL HEMP3 weeks ago

Cronos Group Inc. (NASDAQ:CRON) Spends $300 Million On CBD Skincare Businesses

Post Views: 167 Cronos Group Inc. (NASDAQ:CRON) has not had the best of runs in recent months, after starting the...

INDUSTRIAL HEMP3 weeks ago

Elev8 Brands, Inc. (OTCMKTS:VATE) A Potential Break Out Play On Sales Growth Boost

Post Views: 125 Elev8 Brands, Inc. (OTCMKTS:VATE) stock is a potential break out play as a flurry of positive developments...

INDUSTRIAL HEMP3 weeks ago

Medical Marijuana Inc. (OTCMKTS:MJNA) Eyes Fresh Gains On Improving Fundamentals

Post Views: 82 Medical Marijuana Inc. (OTCMKTS:MJNA) bounce back from all-time lows continues to gather pace on improving fundamentals. Investor’s...

INDUSTRIAL HEMP3 weeks ago

Sugarmade Inc. (OTCMKTS:SGMD) Turns To Hemp Production To Reinvigorate Growth Prospects

Post Views: 95 Sugarmade Inc. (OTCMKTS:SGMD) has made a strategic investment in Hempistry as it tries to reinvigorate its growth...

INDUSTRIAL HEMP7 months ago

Auxly Cannabis Group Inc (OTCMKTS:CBWTF) Acquires 46% Stake In Curative Cannabis And Agrees to Fund Cannabis Cultivation Facility To Produce Ultra Premium Cannabis

Post Views: 47 Auxly Cannabis Group Inc (OTCMKTS:CBWTF) has entered a deal to take over a 46% stake in Curative...

Advertisement

Whats Hot

Create a future where the human body can repair, restore, and rejuvenate itself

 

Trading Symbol

OTC: PLSI

The Next Big Global Cannabis Play